{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T23:21:09Z","timestamp":1747524069760},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12876-015-0401-4","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T13:11:00Z","timestamp":1449148260000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia"],"prefix":"10.1186","volume":"15","author":[{"given":"Chung-Chuan","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai-Hsuan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Long","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Sheng","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien-Chien","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Hwa","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"key":"401_CR1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","volume":"347","author":"S Suerbaum","year":"2002","unstructured":"Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175\u201386.","journal-title":"N Engl J Med"},{"key":"401_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/gut.51.1.15","volume":"51","author":"PI Hsu","year":"2002","unstructured":"Hsu PI, Lai KH, Lo GH, Tseng HH, Lo CC, Chen HC, et al. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients. Gut. 2002;51:15\u201320.","journal-title":"Gut"},{"key":"401_CR3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.49.3.347","volume":"49","author":"Helicobacter and Cancer Collaborative Group","year":"2001","unstructured":"Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49:347\u201353.","journal-title":"Gut"},{"key":"401_CR4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","volume":"345","author":"N Uemura","year":"2001","unstructured":"Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter infection and the development of gastric cancer. N Engl J Med. 2001;345:784\u20139.","journal-title":"N Engl J Med"},{"key":"401_CR5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM199405053301803","volume":"330","author":"J Parsonnet","year":"1994","unstructured":"Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lumphoma. N Engl J Med. 1994;330:1267\u201371.","journal-title":"N Engl J Med"},{"key":"401_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-151-2-200907210-00009","volume":"151","author":"L Fuccio","year":"2009","unstructured":"Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009;151:121\u20138.","journal-title":"Ann Intern Med"},{"key":"401_CR7","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1440-1746.2009.05982.x","volume":"24","author":"KM Fock","year":"2009","unstructured":"Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009;24:1587\u2013600.","journal-title":"J Gastroenterol Hepatol"},{"key":"401_CR8","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","volume":"102","author":"WD Chey","year":"2007","unstructured":"Chey WD, Wong BC. Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808\u201325.","journal-title":"Am J Gastroenterol"},{"key":"401_CR9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, Atherton J, Axon ATR, Bazzoli F, et al. The European Helicobacter Study Group (EHSG). Management of Helicobacter pylori infection \u2013 the Maastricht IV\/ Florence consensus report. Gut. 2012;61:646\u201364.","journal-title":"Gut"},{"key":"401_CR10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","volume":"59","author":"DY Graham","year":"2010","unstructured":"Graham DY, Fischbach LA. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010;59:1143\u201353.","journal-title":"Gut"},{"key":"401_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrgastro.2010.210","volume":"8","author":"E Rimbara","year":"2011","unstructured":"Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol. 2011;8:79\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"401_CR12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","volume":"62","author":"F Megraud","year":"2013","unstructured":"Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62:34\u201342.","journal-title":"Gut"},{"key":"401_CR13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1365-2036.2003.01461.x","volume":"17","author":"A Zullo","year":"2003","unstructured":"Zullo A, Vaira D, Vakil N, Hassan C, Gatta L, Ricci C, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther. 2003;17:719\u201326.","journal-title":"Aliment Pharmacol Ther"},{"key":"401_CR14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7326\/0003-4819-146-8-200704170-00006","volume":"146","author":"D Vaira","year":"2007","unstructured":"Vaira D, Zullo A, Vakil N, Gatta L, Ricci C, Perna F, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann Intern Med. 2007;146:556\u201363.","journal-title":"Ann Intern Med"},{"key":"401_CR15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7326\/0003-4819-148-12-200806170-00226","volume":"148","author":"NS Jafri","year":"2008","unstructured":"Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for helicobacter pylori infection in patients na\u00efve to treatment. Ann Intern Med. 2008;148:923\u201331.","journal-title":"Ann Intern Med"},{"key":"401_CR16","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1038\/ajg.2009.555","volume":"104","author":"L Gatta","year":"2009","unstructured":"Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol. 2009;104:3069\u201379.","journal-title":"Am J Gastroenterol"},{"key":"401_CR17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1365-2036.1998.00351.x","volume":"12","author":"GA Neil","year":"1998","unstructured":"Neil GA, Suchower LJ, Johnson E, Ronca PD, Skoglund ML. Helicobacter pylori eradication as a surrogate marker for the reduction of duodenal ulcer recurrence. Aliment Pharmacol Ther. 1998;12:619\u201333.","journal-title":"Aliment Pharmacol Ther"},{"key":"401_CR18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2036.2002.01174.x","volume":"16","author":"JS Kim","year":"2002","unstructured":"Kim JS, Kim SG, Choi IJ, Park MJ, Kim BG, Jung HC, et al. Effect of Helicobacter pylori eradication on duodenal ulcer scar in patient with no clinical history of duodenal ulcer. Aliment Pharmacol Ther. 2002;16:275\u201380.","journal-title":"Aliment Pharmacol Ther"},{"key":"401_CR19","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1365-2036.2001.01014.x","volume":"15","author":"S Bruley des Varannes","year":"2001","unstructured":"Bruley des Varannes S, Flejou JF, Colin R, Za\u00efm M, Meunier A, Bidaut-Mazel C. There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2001;15:1177\u201385.","journal-title":"Aliment Pharmacol Ther"},{"key":"401_CR20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/bmj.319.7216.1040","volume":"319","author":"RL Jaakkimainen","year":"1999","unstructured":"Jaakkimainen RL, Boyle E, Tudiver F. Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis. BMJ. 1999;319:1040\u20134.","journal-title":"BMJ"},{"key":"401_CR21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00042737-200111000-00007","volume":"13","author":"JP Gisbert","year":"2001","unstructured":"Gisbert JP, Marcos S, Gisbert JL, Pajares M. Helicobacter pylori eradication therapy is more effect in peptic ulcer than in non-ulcer dyspepsia. Eur J Gastroenterol Hepatol. 2001;13:1303\u20137.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"401_CR22","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3748\/wjg.v11.i18.2726","volume":"11","author":"JQ Huang","year":"2005","unstructured":"Huang JQ, Zheng GF, Hunt RH, Wong WM, Lam SK, Karlberg J, et al. Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. World J Gastroenterol. 2005;11:2726\u201332.","journal-title":"World J Gastroenterol"},{"key":"401_CR23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/gut.48.3.287","volume":"48","author":"D Vaira","year":"2001","unstructured":"Vaira D, Vakil N. Blood, urine, stool, breath, money, and Helicobacter pylori. Gut. 2001;48:287\u20139.","journal-title":"Gut"},{"key":"401_CR24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1523-5378.1998.08029.x","volume":"3","author":"F Bazzoli","year":"1998","unstructured":"Bazzoli F, Pozzato P, Zagari M, Fossi S, Ricciardiello L, Nicolini G, et al. Efficacy of lansopraole in eradicating Helicobacter pylori: a meta-analysis. Helicobacter. 1998;3:195\u2013201.","journal-title":"Helicobacter"},{"key":"401_CR25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2036.1999.00542.x","volume":"13","author":"RJ Laheij","year":"1999","unstructured":"Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection- a meta-analysis. Aliment Pharmacol Ther. 1999;13:857\u201364.","journal-title":"Aliment Pharmacol Ther"},{"key":"401_CR26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ajg.2009.708","volume":"105","author":"N Sirimontaporn","year":"2010","unstructured":"Sirimontaporn N, Thong-Ngam D, Tumwasorn S, Mahachai V. Ten-day sequential therapy of Helicobacter pylori infection in Thailand. Am J Gastroenterol. 2010;105:1071\u20135.","journal-title":"Am J Gastroenterol"},{"key":"401_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2036.2011.04902.x","volume":"35","author":"HG Park","year":"2012","unstructured":"Park HG, Jung MK, Jung JT, Kwon JG, Kim EY, Seo HE, et al. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in na\u00efve patients. Aliment Pharmacol Ther. 2012;35:56\u201365.","journal-title":"Aliment Pharmacol Ther"},{"key":"401_CR28","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1440-1746.2012.07249.x","volume":"27","author":"JW Chung","year":"2012","unstructured":"Chung JW, Jung YK, Kim YJ, Kwon KA, Kim JH, Lee JJ, et al. Ten-day sequential versus triple therapy for Helicobacter pylori eradications: a prospective, open-label, randomized trial. J Gastroenterol Hepatol. 2012;27:1675\u201380.","journal-title":"J Gastroenterol Hepatol"},{"key":"401_CR29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","volume":"381","author":"JM Liou","year":"2013","unstructured":"Liou JM, Chen CC, Chen MJ, Chen CC, Chan CY, Fang YJ, et al. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet. 2013;381:205\u201313.","journal-title":"Lancet"},{"key":"401_CR30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ajg.2014.26","volume":"109","author":"L Zhou","year":"2014","unstructured":"Zhou L, Zhang J, Chen M, Hou X, Li Z, Song Z, et al. A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial. Am J Gastroenterol. 2014;109:535\u201341.","journal-title":"Am J Gastroenterol"},{"key":"401_CR31","doi-asserted-by":"crossref","first-page":"f4587","DOI":"10.1136\/bmj.f4587","volume":"347","author":"L Gatta","year":"2013","unstructured":"Gatta L, Vakil N, Vaira D, Scarpignato C. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ. 2013;347:f4587.","journal-title":"BMJ"},{"key":"401_CR32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1523-5378.2007.00518.x","volume":"12","author":"DY Graham","year":"2007","unstructured":"Graham DY, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy. Helicobacter. 2007;12:275\u20138.","journal-title":"Helicobacter"},{"key":"401_CR33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2710.2008.00969.x","volume":"34","author":"JL Tong","year":"2009","unstructured":"Tong JL, Ran ZH, Shen J, Xiao SD. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis. J Clin Pharm Ther. 2009;34:41\u201353.","journal-title":"J Clin Pharm Ther"},{"key":"401_CR34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MCG.0b013e3181c8a1a3","volume":"44","author":"JP Gisber","year":"2010","unstructured":"Gisber JP, Calvet X, O\u2019Connor A, M\u00e9graud F, O\u2019Morain CA. Sequential therapy for Helicobacter pylori eradication : a critical review. J Clin Gastroenterol. 2010;44:313\u201325.","journal-title":"J Clin Gastroenterol"},{"key":"401_CR35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1440-1746.2011.06885.x","volume":"27","author":"FW Tsay","year":"2012","unstructured":"Tsay FW, Tseng HH, Hsu PI, Wang KM, Lee CC, Chang SN, et al. Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan. J Gastroenterol Hepatol. 2012;27:498\u2013503.","journal-title":"J Gastroenterol Hepatol"},{"key":"401_CR36","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00042737-200111000-00002","volume":"13","author":"WA Boer de","year":"2001","unstructured":"de Boer WA, Tytgat GN. Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis? Eur J Gastroenterol Hepatol. 2001;13:1281\u20134.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"401_CR37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S1590-8658(01)80044-X","volume":"33","author":"V Francesco De","year":"2001","unstructured":"De Francesco V, Zullo A, Hassan C, Faleo D, Ierardi E, Panella C, et al. Two new treatment regiments for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective randomized study. Dig Liver Dis. 2001;33:676\u20139.","journal-title":"Dig Liver Dis"},{"key":"401_CR38","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gut.2007.125658","volume":"56","author":"A Zullo","year":"2007","unstructured":"Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut. 2007;56:1353\u20137.","journal-title":"Gut"},{"key":"401_CR39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1365-2036.1999.00471.x","volume":"13","author":"SJ Zanten","year":"1999","unstructured":"Zanten SJ, Bradette M, Farley A, Leddin D, Lind T, Unge P, et al. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther. 1999;13:289\u201395.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"401_CR40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2036.1999.00535.x","volume":"13","author":"P Malfertheiner","year":"1999","unstructured":"Malfertheiner P, Bayerd\u00f6rffer E, Diete U, Gil J, Lind T, Misiuna P. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther. 1999;13(6):703\u201312.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-015-0401-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T04:07:44Z","timestamp":1653710864000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-230X\/15\/170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["401"],"URL":"https:\/\/doi.org\/10.1186\/s12876-015-0401-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"170"}}